Navigation Links
Preclinical Studies Identify Novel Approach for Enhancing the,Anticancer Activity of Introgen's INGN 241

ivation. The studies also identified two other proteins, MEKK1 and caspase-3, which mediate the cell-killing effects of INGN 241.

Based on these results, it is anticipated that the combination of INGN 241 and inhibitors of NF-kB will have an enhanced therapeutic effect and be suitable for clinical evaluation.

About INGN 241

INGN 241 is being tested in a Phase 2 clinical trial for patients suffering from advanced melanoma and in a Phase 3 clinical trial in combination with radiation therapy in solid tumors. The mda-7 gene is the active component of INGN 241 and was discovered in the laboratory of Dr. Paul B. Fisher, professor of clinical pathology at Columbia University. Introgen holds an exclusive worldwide sublicense to the Columbia University rights for all gene therapy applications from GlaxoSmithKline.

About Introgen

Introgen Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer and other diseases. Introgen is developing molecular therapeutics, immunotherapies, vaccines and nano-particle tumor suppressor therapies to treat a wide range of cancers using tumor suppressors, cytokines and genes. Introgen maintains integrated research, development, manufacturing, clinical and regulatory departments and operates multiple manufacturing facilities including a commercial scale cGMP manufacturing facility.

Introgen holds a licensing agreement with M. D. Anderson Cancer Center to commercialize products based on licensed technologies, and has the option to license future technologies under sponsored research agreements. The University of Texas Board of Regents owns stock in Introgen. These arrangements are managed in accordance with M. D. Anderson's conflict of interest policies.

Statements in this release that are not strictly historical may be "forward-looking" statements, including those relating to Introgen'
'"/>




Page: 1 2 3

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
3. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
4. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
5. ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
6. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
7. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
8. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
9. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
10. Metabasis Therapeutics Presents Results of Preclinical Studies for MB07811, Its Novel Product Candidate for the Treatment of Hyperlipidemia, at the Endocrine Societys Annual Meeting
11. Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control
Post Your Comments:
(Date:7/14/2014)... DIEGO , July 14, 2014  Diomics, ... material, today announced that the United States Patent ... held by Diomics covering novel biologic sample collection ... their use in forensics and diagnostics. ... materials is by swabbing. Recovery of DNA from ...
(Date:7/14/2014)... ANAHEIM, Calif. , July 14, 2014  Mallinckrodt plc ... QCOR ) today announced that the registration statement ... Commission ("SEC") by Mallinckrodt plc on May 16, 2014 and ... statement of Mallinckrodt and Questcor that also constitutes a prospectus ... registration statement on Form S-4 is available on the SEC,s ...
(Date:7/14/2014)... Francisco, Calif. , July 14, 2014 ... today announces a technology partnership with global ... develop its technology for quick-to-market products. ... approach and DNA2.0,s machine learning optimization technologies, ... speeding up the process of engineering proteins ...
Breaking Medicine Technology:Diomics Announces Issuance Of U.S. Patents For Novel Biologic Sample DNA Collection Materials For Use In Forensics And Diagnostics 2Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 2Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 3Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 4Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 5Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 6Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 7Pareto Biotechnologies Announces Technology Partnership With DNA2.0, Inc. 2Pareto Biotechnologies Announces Technology Partnership With DNA2.0, Inc. 3
... WASHINGTON, June 20, 2007 /PRNewswire-USNewswire/ -- Speaker,Nancy Pelosi ... Bush's veto of the stem cell bill: , ... of the American,people, of leading medical researchers, and ... veto says 'no' to the hopes of,million of ...
... Research and,Markets (http://www.researchandmarkets.com/reports/c60415) has,announced the addition of ... advancements in molecular research and continued untiring,efforts ... more precisely,applicable Pharmaceuticals as well as agro ... advent of Chiral technologies and their,applications. , ...
Cached Medicine Technology:New Report 'Looking at Chiral Technologies' Analyzes the Global,Market Growth Forecasts Driven By Two Very Important Components as,Single Isomer Drugs and Single Enantiomer Pharmaceuticals 2
(Date:7/14/2014)... (PRWEB) July 14, 2014 Many people ... people undergo plastic surgery to reduce a “double chin.” ... however, eliminates the need to go under the knife. ... works the jaw muscles, therefore tightening the skin in ... chins. , Jawflex is used for facial exercise, double ...
(Date:7/14/2014)... San Francisco, California (PRWEB) July 14, 2014 ... is expected to reach USD 4,285.1 million by ... to a new study by Grand View Research, ... of computational biology for bioinformatics R&D programs designed ... and increasing number of clinical studies in pharmacogenomics ...
(Date:7/14/2014)... The NIH is giving $8 million ... fund a clinical trial on light-based therapy in mesothelioma ... newly-posted article on the research. , Scientists at ... to enroll 102 pleural mesothelioma study participants ... photosensitizing drug prior to surgery. Then half will have ...
(Date:7/14/2014)... VA (PRWEB) July 14, 2014 Since ... a local icon to the Tysons Corner skyline and ... becoming its own municipality, known simply as “Tysons”, the ... Tysons Hotel. In addition to Tysons becoming its ... located in the heart of Tysons brings an evolution ...
(Date:7/14/2014)... 14, 2014 July 14, 2014 ... in enterprise-class cloud management, governance, and compliance software ... AvePoint software will be available to customers of ... , The hosting and value-added reseller ... following AvePoint solutions to new or existing customers: ...
Breaking Medicine News(10 mins):Health News:Jawflex | Double Chin Exercise for Double Chin Reduction 2Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 2Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 3Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 4Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 5Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 6Health News:New Research Could Expand Availability of Light-Based Mesothelioma Therapy, According to Surviving Mesothelioma 2Health News:Iconic Tyson’s Corner Hotel Embraces the New “Tysons” Evolution 2Health News:Iconic Tyson’s Corner Hotel Embraces the New “Tysons” Evolution 3Health News:Iconic Tyson’s Corner Hotel Embraces the New “Tysons” Evolution 4Health News:AvePoint Works with Rackspace to Extend Vital Management Features to Hybrid SharePoint Deployments 2Health News:AvePoint Works with Rackspace to Extend Vital Management Features to Hybrid SharePoint Deployments 3
... 24 Prime Therapeutics (Prime), a,thought leader in ... has joined the organization as Vice President of,Pharmacy ... Trade Relations, Wan will focus on,developing and maintaining ... efforts in the development of strategic pharmacy,contracts and ...
... Experts offer advice on how to use the Internet to ... Internet offers a dizzying amount of health information -- whatever ... it somewhere on the Web. , But all that information ... up heeding the wrong voice and getting some fairly bad ...
... Fla., April 24 Life Brokerage Partners,announces three ... Inc. ("Peachtree"), Polaris and United National Finance,Inc. ("UNF"). ... agents because they provide new methods for transacting,business., ... Peachtree, Polaris and UNF,do not end with the ...
... STAAR Surgical,Company (Nasdaq: STAA ) today announced ... ended March 28, 2008 on Tuesday, May 6, 2008,after ... call and webcast,on Tuesday, May 6, 2008 at 5:00 ... current corporate developments. The dial-in number for,the conference call ...
... Trend Expert Addresses Impact of Technology on Health; Fitness Expert ... Denise Austin Offers Nightly Wellness Tips, MORRIS ... do you reach for your cell phone or your gym bag? ... Antiseptic,shows that Americans are busier than ever before, often at the ...
... MIAMI, April 24 Physicians Healthcare,Management Group, Inc. ... organizations (HMOs) in partnership with physicians,today announced that ... signed an agreement with Advantica EyeCare to provide,comprehensive ... be launched in,the latter half of 2008., ...
Cached Medicine News:Health News:The 'Net: A Tangled Web of Health Information 2Health News:The 'Net: A Tangled Web of Health Information 3Health News:Life Brokerage Partners Strengthens Premium Finance Programs 2Health News:STAAR Surgical Announces First Quarter 2008 Earnings Release Date and Conference Call 2Health News:Wired, Working Americans Let Nighttime Health Routines Slide 2Health News:Wired, Working Americans Let Nighttime Health Routines Slide 3Health News:Wired, Working Americans Let Nighttime Health Routines Slide 4Health News:Phyhealth Signs Agreement with Advantica EyeCare to Provide Vision Services for Pilot HMO 2
... its kind, the noncontact EnSite Array ... electrical information, translating it into a ... this unique tool simplifies ablation procedures ... of electrical data in a single ...
Wire mesh braided design with a platinum core....
... Medical's universal programmer platform, the Model ... combination with St. Jude Medical® bradycardia ... emerging indications. Features a large, ... matrix LCD screen Programmer offers continuous, ...
Inquire...
Medicine Products: